BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26725534)

  • 21. BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations.
    Masir N; Campbell LJ; Goff LK; Jones M; Marafioti T; Cordell J; Clear AJ; Lister TA; Mason DY; Lee AM
    Br J Haematol; 2009 Mar; 144(5):716-25. PubMed ID: 19120369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
    Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
    Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.
    Howard MT; Dufresne S; Swerdlow SH; Cook JR
    Am J Clin Pathol; 2009 May; 131(5):656-62. PubMed ID: 19369624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation.
    Schraders M; de Jong D; Kluin P; Groenen P; van Krieken H
    J Pathol; 2005 Feb; 205(3):329-35. PubMed ID: 15682435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare face of follicular lymphoma: reverse variant of follicular lymphoma.
    Maskey N; Chen Q; Liu F; Liu S; Tian S
    Diagn Pathol; 2020 Apr; 15(1):31. PubMed ID: 32245492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.
    Barreca A; Martinengo C; Annaratone L; Righi L; Chiappella A; Ladetto M; Demurtas A; Chiusa L; Stacchini A; Crosetto N; van Oudenaarden A; Chiarle R
    Blood Cancer J; 2014 Oct; 4(10):e249. PubMed ID: 25303368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma.
    Yin CC; Luthra R
    Methods Mol Biol; 2013; 999():203-9. PubMed ID: 23666699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and predictive significance of the bcl-2/IgH translocation in malignant follicular lymphomas.
    Georgescu A; Stoicea M; Comănescu M; Dobrea C; Andrei F; Neagu M; Cionca F; Ciobanu A; Lupu A; Ardeleanu C
    Rom J Morphol Embryol; 2010; 51(4):687-91. PubMed ID: 21103627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
    Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
    Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
    Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
    Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [t(14:18) chromosomal translocation and over expression of bcl-2 protein in follicular type non-Hodgkin's lymphoma].
    Wang J; Li G; Liu Z
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):337-40. PubMed ID: 8732086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
    Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
    Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heterogeneity of follicular lymphomas: from early development to transformation.
    Xerri L; Dirnhofer S; Quintanilla-Martinez L; Sander B; Chan JK; Campo E; Swerdlow SH; Ott G
    Virchows Arch; 2016 Feb; 468(2):127-39. PubMed ID: 26481245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
    Masir N; Campbell LJ; Jones M; Mason DY
    Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.